Applied Dna Sciences Stock Today
| APDN Stock | USD 0.34 0.01 3.03% |
Performance0 of 100
| Odds Of DistressOver 80
|
Applied DNA is selling at 0.34 as of the 19th of April 2024; that is 3.03 percent increase since the beginning of the trading day. The stock's open price was 0.33. Applied DNA has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Applied DNA Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Technology Hardware & Equipment | IPO Date 15th of July 2003 | Category Healthcare | Classification Information Technology |
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company has 16.98 M outstanding shares of which 270.82 K shares are presently shorted by private and institutional investors with about 1.67 trading days to cover. More on Applied DNA Sciences
Moving together with Applied Stock
| 0.61 | EXTR | Extreme Networks Financial Report 24th of April 2024 | PairCorr |
Moving against Applied Stock
| 0.85 | WDC | Western Digital Earnings Call This Week | PairCorr |
| 0.81 | DM | Desktop Metal Financial Report 8th of May 2024 | PairCorr |
| 0.81 | NTAP | NetApp Inc Financial Report 29th of May 2024 | PairCorr |
| 0.8 | MSI | Motorola Solutions Financial Report 2nd of May 2024 | PairCorr |
| 0.77 | HPE | Hewlett Packard Ente Financial Report 4th of June 2024 | PairCorr |
| 0.73 | PSTG | Pure Storage Financial Report 29th of May 2024 | PairCorr |
| 0.68 | RCAT | Red Cat Holdings Tech Boost | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Applied Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Applied DNA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Applied DNA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | James Hayward | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Electronic Equipment, Instruments & Components, Technology Hardware & Equipment, Information Technology, NASDAQ Composite, NASDAQ Composite Total, Information Technology, Electronic Equipment, Instruments & Components, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Applied DNA report their recommendations after researching Applied DNA's financial statements, talking to executives and customers, or listening in on Applied DNA's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Applied DNA Sciences. The Applied consensus assessment is calculated by taking the average forecast from all of the analysts covering Applied DNA. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Applied DNA's financial statements, Applied DNA Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in May. Financial strength of Applied DNA Sciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Applied DNA's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Applied DNA's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Applied DNA's financial leverage. It provides some insight into what part of Applied DNA's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Applied DNA Sciences (APDN) is traded on NASDAQ Exchange in USA. It is located in 50 Health Sciences Drive, Stony Brook, NY, United States, 11790 and employs 52 people. Applied DNA is listed under Electronic Equipment, Instruments & Components category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Applied DNA's market, we take the total number of its shares issued and multiply it by Applied DNA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Applied DNA Sciences conducts business under Electronic Equipment, Instruments & Components sector and is part of Information Technology industry. The entity has 16.98 M outstanding shares of which 270.82 K shares are presently shorted by private and institutional investors with about 1.67 trading days to cover.
Applied DNA Sciences currently holds about 4.68 M in cash with (6.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Applied DNA Probability Of Bankruptcy
Ownership AllocationApplied DNA Sciences retains a total of 16.98 Million outstanding shares. Applied DNA Sciences shows 12.31 percent of its outstanding shares held by insiders and 19.2 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Applied Ownership Details
Applied Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Applied DNA jumping above the current price in 90 days from now is about 97.0%. The Applied DNA Sciences probability density function shows the probability of Applied DNA stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.393. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Applied DNA will likely underperform. Additionally, applied DNA Sciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Applied DNA to move above the current price in 90 days from now is about 97.0 (This Applied DNA Sciences probability density function shows the probability of Applied Stock to fall within a particular range of prices over 90 days) .
Applied Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Applied DNA that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Applied DNA's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Applied DNA's value.| Instituion | Recorded On | Shares | |
| Hm Payson & Co | 2023-12-31 | 15.4 K | |
| Natixis Sa | 2023-12-31 | 13.5 K | |
| Creative Planning Inc | 2023-12-31 | 10.5 K | |
| Wells Fargo & Co | 2023-12-31 | 2.9 K | |
| Cutler Group Lp | 2023-12-31 | 2.8 K | |
| Tower Research Capital Llc | 2023-12-31 | 2.3 K | |
| Royal Bank Of Canada | 2023-12-31 | 1.7 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 656 | |
| Bank Of America Corp | 2023-12-31 | 341 | |
| Vanguard Group Inc | 2023-12-31 | 523.7 K | |
| Amh Equity Ltd | 2023-12-31 | 370 K |
Applied DNA Historical Income Statement
Applied DNA Sciences Income Statement is one of the three primary financial statements used for reporting Applied's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Applied DNA Sciences revenue and expense. Applied DNA Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Applied DNA's Research Development is very stable compared to the past year. As of the 19th of April 2024, Total Revenue is likely to grow to about 16.1 M, though Interest Expense is likely to grow to (11.3 M). View More FundamentalsApplied Stock Against Markets
Picking the right benchmark for Applied DNA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Applied DNA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Applied DNA is critical whether you are bullish or bearish towards Applied DNA Sciences at a given time. Please also check how Applied DNA's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Applied DNA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Applied DNA Corporate Directors
Applied DNA corporate directors refer to members of an Applied DNA board of directors. The board of directors generally takes responsibility for the Applied DNA's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Applied DNA's board members must vote for the resolution. The Applied DNA board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Sanford Simon | Director and Member of Nominating Committee | Profile | |
| Robert Catell | Director | Profile | |
| John Bitzer | Independent Director | Profile | |
| Yacov Shamash | Independent Director | Profile |
How to buy Applied Stock?
Before investing in Applied DNA, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Applied DNA. To buy Applied DNA stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Applied DNA. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Applied DNA stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Applied DNA Sciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Applied DNA Sciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Applied DNA Sciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Applied Stock please use our How to Invest in Applied DNA guide.
Already Invested in Applied DNA Sciences?
The danger of trading Applied DNA Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Applied DNA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Applied DNA. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Applied DNA Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Applied DNA Sciences information on this page should be used as a complementary analysis to other Applied DNA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Applied Stock analysis
When running Applied DNA's price analysis, check to measure Applied DNA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied DNA is operating at the current time. Most of Applied DNA's value examination focuses on studying past and present price action to predict the probability of Applied DNA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied DNA's price. Additionally, you may evaluate how the addition of Applied DNA to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Applied DNA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Revenue Per Share 0.678 | Quarterly Revenue Growth (0.83) | Return On Assets (0.56) | Return On Equity (1.10) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.